Generated by AI
Endovia Health Sciences, Inc. is a health sciences company focused on cannabinoid-based pharmaceutical, veterinary, and consumer wellness products. The company develops and commercializes differentiated health technologies across regulated human and animal health markets, with current emphasis on commercial pharmaceutical assets and FDA-regulated therapeutics. Its portfolio includes cannabinoid-based programs such as CannEpil®, which is being advanced for veterinary applications, alongside wellness-oriented offerings that extend its reach into consumer-facing health categories. Endovia Health Sciences operates as a diversified platform that combines product development, regulatory work, and market commercialization across multiple segments of the cannabinoid industry. The company serves markets that include pharmaceuticals, companion-animal health, and wellness products, positioning it as a specialized participant in emerging cannabinoid healthcare applications.
Website1314 East Las Olas Boulevard
Fort Lauderdale, FL, 33301
United States
The latest articles about SBEV.
FDA establishes Investigational New Animal Drug (INAD) File No. 14145, advancing the Company's companion-animal oncology program and marking first milestone under Lupvindol collaboration
New corporate identity and ticker reflect the Company’s transformation into a diversified cannabinoid-based health sciences platformFORT LAUDERDALE, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company”) today announced that its corporate name will change to Endovia Health Sciences, Inc., and its common stock will begin trading on the NYSE American under the new ticker symbol “EDVA” effective at market open at 9:30 a.m. Eastern Time on Monday, A
Summary of Aug 21's posts. Generated by AI.
Summary of Jul 31's posts. Generated by AI.
Summary of Aug 12's posts. Generated by AI.
Investors talking about SBEV also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.